CRYSTAL VOEGELI: Open Payments
NPI 1295173722 · PORT ARTHUR, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$834 in 53 payments from 16 companies in 2025. Trend: 2023 $661 · 2024 $707 · 2025 $834
Food & beverage: $834
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $301 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $67 |
| GlaxoSmithKline, LLC. | 3 | $56 |
| Axsome Therapeutics, Inc. | 3 | $55 |
| Novo Nordisk Inc | 3 | $52 |
| AstraZeneca Pharmaceuticals LP | 2 | $41 |
| Lilly USA, LLC | 2 | $38 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $35 |
| Amgen Inc. | 2 | $34 |
| Phathom Pharmaceuticals, Inc. | 2 | $33 |
Products named: VRAYLAR, QULIPTA, Kerendia, TRELEGY ELLIPTA, Auvelity, UBRELVY, CAPLYTA, Rybelsus.
Industry payments across TX — which companies pay providers there.
